Kersten Small

Kersten Small has extensive work experience in the field of preclinical and translational sciences. Currently, they hold the position of Head of Preclinical and Translational Sciences at Selah Therapeutics, as well as the role of Director of Research and Early Development at Juvenescence™️.

Prior to these positions, Kersten served as the Deputy Director of Clinical Programs at Cohen Veterans Bioscience from 2020 to 2022. Kersten also worked as the Director of Medical Science and Translational Research at Mitsubishi Tanabe Pharma Development America from 2017 to 2020.

Before transitioning to industry roles, Kersten held various positions at Merck, including Principal Scientist from 2012 to 2017 and Research Fellow from 2005 to 2012. Kersten began their career in academia, working as a Research Associate Professor at the University of Cincinnati from 2002 to 2005 and as a Research Assistant Professor from 1998 to 2002.

Kersten's academic journey started with a Post Doctoral Fellowship at Emory University from 1994 to 1997. Overall, their work experience spans both academic and industry settings, encompassing leadership roles, research and development, and clinical program management.

Kersten Small earned a Bachelor of Science degree in Biology from Purdue University from 1983 to 1987. Continuing their education, they attended the University of Cincinnati from 1987 to 1993, obtaining a Ph.D. However, the specific field of study for their Ph.D. is not available.